Published in Vector Borne Zoonotic Dis on January 01, 2008
Severe human infection with Rickettsia felis associated with hepatitis in Yucatan, Mexico. Int J Med Microbiol (2009) 0.94
Human rickettsialpox, southeastern Mexico. Emerg Infect Dis (2009) 0.85
Epidemiological study of rickettsial infections in patients with hypertransaminemia in Madrid (Spain). Int J Environ Res Public Health (2009) 0.79
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Lyme borreliosis. Lancet (2011) 4.81
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med (2012) 4.15
Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med (2012) 3.79
Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med (2005) 3.58
Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep (2006) 3.32
Subjective symptoms after treatment of early Lyme disease. Am J Med (2010) 3.22
Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species. N Engl J Med (2007) 3.18
Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis (2003) 3.18
Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study. PLoS Negl Trop Dis (2013) 2.99
Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 2.88
Common misconceptions about Lyme disease. Am J Med (2013) 2.84
Treatment trials for post-Lyme disease symptoms revisited. Am J Med (2013) 2.75
MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 2.67
Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun (2010) 2.50
Southern Tick-Associated Rash Illness (STARI) in the North: STARI following a tick bite in Long Island, New York. Clin Infect Dis (2011) 2.19
Human Borrelia miyamotoi infection in the United States. N Engl J Med (2013) 2.11
First detection of heartland virus (Bunyaviridae: Phlebovirus) from field collected arthropods. Am J Trop Med Hyg (2013) 2.06
Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep (2013) 2.06
Tick-borne diseases in North Carolina: is "Rickettsia amblyommii" a possible cause of rickettsiosis reported as Rocky Mountain spotted fever? Vector Borne Zoonotic Dis (2008) 2.05
Rickettsia 364D: a newly recognized cause of eschar-associated illness in California. Clin Infect Dis (2010) 2.00
Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis (2002) 1.97
Infection with Anaplasma phagocytophila in cervids from Slovenia: evidence of two genotypic lineages. Wien Klin Wochenschr (2002) 1.88
Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. N Engl J Med (2011) 1.84
The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg (2008) 1.82
Reinfection in patients with Lyme disease. Clin Infect Dis (2007) 1.81
Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother (2010) 1.75
Bartonella species in blood of immunocompetent persons with animal and arthropod contact. Emerg Infect Dis (2007) 1.73
Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis (2008) 1.71
Serologic markers of Lyme disease in children with autism. JAMA (2013) 1.67
Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania. Clin Infect Dis (2011) 1.66
Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med (2003) 1.62
Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study. Vector Borne Zoonotic Dis (2013) 1.59
Seroprevalence of Q fever in the United States, 2003-2004. Am J Trop Med Hyg (2009) 1.51
Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med (2012) 1.50
Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45
Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45
Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor. Liver Transpl (2004) 1.44
Why has Borrelia burgdorferi not been transmitted by blood transfusion? Transfusion (2013) 1.42
Poly-ticks: Blue State versus Red State for Lyme disease. Lancet (2005) 1.42
Potentiation of acetaminophen hepatotoxicity by phenytoin, leading to liver transplantation. Dig Dis Sci (2005) 1.41
Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol (2002) 1.40
Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36
Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol (2006) 1.34
Comparison of the reservoir competence of medium-sized mammals and Peromyscus leucopus for Anaplasma phagocytophilum in Connecticut. Vector Borne Zoonotic Dis (2002) 1.34
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med (2007) 1.29
The expanding spectrum of eschar-associated rickettsioses in the United States. Arch Dermatol (2010) 1.24
Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis (2011) 1.24
Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol (2003) 1.24
Improving the yield of blood cultures from patients with early Lyme disease. J Clin Microbiol (2011) 1.22
Rickettsia parkeri Rickettsiosis, Argentina. Emerg Infect Dis (2011) 1.22
Isolation of Bartonella quintana from a woman and a cat following putative bite transmission. J Clin Microbiol (2006) 1.21
Bartonella spp. transmission by ticks not established. Emerg Infect Dis (2010) 1.19
Murine typhus in Austin, Texas, USA, 2008. Emerg Infect Dis (2010) 1.18
Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome. Clin Immunol (2011) 1.18
Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis. Appl Environ Microbiol (2008) 1.16
2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test. Clin Infect Dis (2010) 1.15
Geographic disparity: the dilemma of lower socioeconomic status, multiple listing, and death on the liver transplant waiting list. Clin Transplant (2014) 1.14
Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States. Emerg Infect Dis (2014) 1.13
Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol (2002) 1.11
A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr (2005) 1.10
Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. Diagn Microbiol Infect Dis (2012) 1.10
Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome. Clin Vaccine Immunol (2011) 1.09
Fatal hemorrhagic fever caused by West Nile virus in the United States. Clin Infect Dis (2006) 1.08
Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect Immun (2004) 1.08
MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis (2013) 1.08
Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States. J Clin Microbiol (2011) 1.07
Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One (2013) 1.07
Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Ann Surg Oncol (2008) 1.05
Afebrile spotted fever group Rickettsia infection after a bite from a Dermacentor variabilis tick infected with Rickettsia montanensis. Vector Borne Zoonotic Dis (2012) 1.04
Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status. J Clin Microbiol (2002) 1.02
Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) (2009) 1.02
Serologic evidence for exposure to Rickettsia rickettsii in eastern Arizona and recent emergence of Rocky Mountain spotted fever in this region. Vector Borne Zoonotic Dis (2006) 1.01
Isolated intestinal transplantation: proof of clinical efficacy. Transplantation (2003) 1.00
Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One (2011) 1.00
Molecular characterization of antibody epitopes of Ehrlichia chaffeensis ankyrin protein 200 and tandem repeat protein 47 and evaluation of synthetic immunodeterminants for serodiagnosis of human monocytotropic ehrlichiosis. Clin Vaccine Immunol (2009) 1.00
Ehrlichiosis and related infections. J Am Vet Med Assoc (2003) 1.00
A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin Diagn Lab Immunol (2005) 0.99
Erythromycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother (2002) 0.98
Isolation and characterization of Bartonella bacilliformis from an expatriate Ecuadorian. J Clin Microbiol (2007) 0.98
Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis (2012) 0.98
Flying squirrel-associated typhus, United States. Emerg Infect Dis (2003) 0.98
The first report of human illness associated with the Panola Mountain Ehrlichia species: a case report. J Med Case Rep (2008) 0.96
Brill-Zinsser disease in a patient following infection with sylvatic epidemic typhus associated with flying squirrels. Clin Infect Dis (2010) 0.95
Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States. Clin Infect Dis (2009) 0.94
Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice. Antimicrob Agents Chemother (2002) 0.94
A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis (2013) 0.93
Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis (2011) 0.92
Oral doxycycline for neuroborreliosis. Lancet Neurol (2008) 0.92
CTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA. Emerg Infect Dis (2013) 0.91
Cluster of sylvatic epidemic typhus cases associated with flying squirrels, 2004-2006. Emerg Infect Dis (2009) 0.91
Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep (2016) 0.90
Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease. Clin Diagn Lab Immunol (2005) 0.89
Cell culture and electron microscopy for identifying viruses in diseases of unknown cause. Emerg Infect Dis (2013) 0.89
Recognition and treatment of erythema migrans: are we off target? Ann Intern Med (2002) 0.88
Vertical transmission of Babesia microti, United States. Emerg Infect Dis (2012) 0.88
An acarologic survey and Amblyomma americanum distribution map with implications for tularemia risk in Missouri. Am J Trop Med Hyg (2011) 0.88
Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. J Clin Microbiol (2012) 0.87
Survey of ticks collected in Mississippi for Rickettsia, Ehrlichia, and Borrelia species. J Vector Ecol (2003) 0.87